This presentation is a part of Sidley’s ongoing AI webinar series and took place on Thursday, October 3, 2024 with former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb.
Artificial intelligence and machine learning have opened the door to revolutionary changes in the life sciences industry. AI is already having a transformative impact on the ways in which FDA and FDA-regulated entities approach the development, manufacturing, use, and oversight of medical products. Our discussion with former Commissioner of the FDA, Dr. Scott Gottlieb, will explore:
- Unique challenges and opportunities presented by the use of AI in the life sciences industry
- Outlook on novel regulatory approaches and considerations faced by regulators
- Future trends in FDA’s regulation of AI, in particular, generative AI
HONORED GUEST
Scott Gottlieb, M.D., Former Commissioner of Food and Drugs, FDA
SIDLEY DISCUSSION MODERATORS
Rebecca K. Wood, Partner and Co-Leader of the Firm’s Food, Drug and Medical Device Practice, and former Chief Counsel, FDA
Deeona Gaskin, Partner and Former Associate Chief Counsel, FDA
ADDITIONAL INFORMATION
Our leading Food, Drug, and Medical Device lawyers draw on their vast experience working with the FDA and unparalleled industry know-how to help guide clients through the shifting AI regulatory landscape. Sidley’s Food, Drug, and Medical Device (FDMD) practice has experience advising clients on the uses of AI throughout a product’s life cycle, including how products are developed, manufactured, and monitored. With its global platform and cross-disciplinary approach, Sidley is uniquely positioned to assist clients embrace opportunities, navigate uncertainties, and prepare for and share their thought leadership on emerging regulatory frameworks.
Please also visit Sidley’s AI Monitor, a centralized resource of content related to AI, including Sidley thought leadership, the latest laws and regulations, and access to our AI lawyers. If you would like to receive AI-related news from Sidley, please click here to subscribe to the mailing list.
For more information about this webinar series, please click here or contact Derek Baker with any questions.
